University of Florida researchers have received approval from the Food and Drug Administration to test an investigational new therapy in a first-in-human clinical trial for participants with primary glioblastoma, the most aggressive malignant brain tumor.
Two MBI members recently earned Innovations of the Year awards at UF Innovate Tech Licensing’s annual Standing InnOvation event recognizing the university’s top innovations. Steven Munger, Ph.D., was awarded for “Adaptive Olfactory Measure of Threshold (ArOMa-T)” a self-administered test to identify dysfunction in the sense of smell. Munger is…
In the mid-1980s, UF neurosurgeon William A. Friedman, M.D., and medical physicist Frank J. Bova, Ph.D., began looking into a lesser-known treatment technique called radiosurgery. After studying then-available technologies, Bova and Friedman came to believe that the existing systems were not only cost prohibitive but also…
UF Health Brain Tumor Education Day is open to all who are impacted by a brain tumor disease throughout the State of Florida and southeastern US. Held on the University of Florida campus, our educational day is an excellent opportunity for guests to ask questions about all brain tumor treatments…
Just four months after Orlando Sentinel editor Beth Kassab’s husband, Grady, was diagnosed with a malignant brain tumor, she received a brain tumor diagnosis of her own.
Diseases of the brain steal: Some steal balance, others memory; some take away the ability to walk, even speak. Some result in a decline that’s long and gradual, or heartbreakingly fast. Each condition is devastating in its own way for those afflicted and for all the people who love them.
November 27, 2017 – The Preston A. Wells, Jr. Center for Brain Tumor Therapy team had an impressive showing at the 2017 Society for Neuro-Oncology, or SNO, meeting in San Francisco, California, held Nov. 16-19. Assistant professor Loic Deleyrolle, Ph.D., and post doctoral fellow Lan Hoang-Minh, Ph.D., received a Top…
